Multiple functions of HMGB1 in cancer

被引:7
|
作者
Lv, Guangyao [1 ]
Yang, Menglin [2 ]
Gai, Keke [1 ]
Jia, Qiong [1 ]
Wang, Zhenzhen [1 ]
Wang, Bin [1 ]
Li, Xueying [3 ]
机构
[1] Binzhou Med Univ Hosp, Dept Pharm, Binzhou, Shandong, Peoples R China
[2] Marine Biomed Res Inst Qingdao, Qual Management Dept, Qingdao, Peoples R China
[3] Binzhou Polytech, Sch Hlth, Binzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
HMGB1; cancer; chemotherapy resistance; autophagy; immunotherapy; GROUP BOX 1; IMMUNOGENIC CELL-DEATH; HMGB1-MEDIATED AUTOPHAGY; PROTEIN HMGB1; ANGIOGENESIS; CHEMOTHERAPY; RESISTANCE; EXPRESSION; PROGRESSION; MIGRATION;
D O I
10.3389/fonc.2024.1384109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High mobility group box 1 (HMGB1) is a nuclear DNA-binding protein with a dual role in cancer, acting as an oncogene and a tumor suppressor. This protein regulates nucleosomal structure, DNA damage repair, and genomic stability within the cell, while also playing a role in immune cell functions. This review comprehensively evaluates the biological and clinical significance of HMGB1 in cancer, including its involvement in cell death and survival, its potential as a therapeutic target and cancer biomarker, and as a prosurvival signal for the remaining cells after exposure to cytotoxic anticancer treatments. We highlight the need for a better understanding of the cellular markers and mechanisms involved in the involvement of HMGB1in cancer, and aim to provide a deeper understanding of its role in cancer progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
    Dong, Haonan
    Zhang, Lu
    Liu, Suling
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (08): : 3421 - 3434
  • [22] Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells
    Yang, Liangchun
    Ye, Fanghua
    Zeng, Li
    Li, Yanling
    Chai, Wenwen
    ONCOTARGETS AND THERAPY, 2020, 13 : 1187 - 1198
  • [23] HMGB1 is a therapeutic target for leukemia
    Yu, Yan
    Xie, Min
    Kang, Rui
    Livesey, Kristen M.
    Cao, Lizhi
    Tang, Daolin
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (01): : 36 - 43
  • [24] Functions of MutLα, Replication Protein A (RPA), and HMGB1 in 5′-Directed Mismatch Repair
    Genschel, Jochen
    Modrich, Paul
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (32) : 21536 - 21544
  • [25] Different measures of HMGB1 location in cancer immunology
    Gorgulho, Carolina Mendonca
    Murthy, Pranav
    Liotta, Lance
    Espina, Virginia
    Lotze, Michael T.
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - MOLECULAR METHODS, 2019, 629 : 195 - 217
  • [27] HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway
    Ning, Jing
    Yang, Rui
    Wang, Hainan
    Cui, Lijuan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)
  • [28] Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review
    Xia, Quansong
    Xu, Juan
    Chen, Huoying
    Gao, Yanzhang
    Gong, Feili
    Hu, Liya
    Yang, Li
    ONCOTARGETS AND THERAPY, 2016, 9 : 3917 - 3923
  • [29] CAMSAP3-mediated regulation of HMGB1 acetylation and subcellular localization in lung cancer cells: Implications for cell death modulation
    Singharajkomron, Natsaranyatron
    Seephan, Suthasinee
    Iksen, Iksen
    Chantaravisoot, Naphat
    Wongkongkathep, Piriya
    Hayakawa, Yoshihiro
    Pongrakhananon, Varisa
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2024, 1868 (06):
  • [30] S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
    Mandarino, Angelo
    Thiyagarajan, Swetha
    Martins, Allana C. F.
    da Silva Gomes, Roberto
    Vetter, Stefan W.
    Leclerc, Estelle
    BIOMOLECULES, 2023, 13 (08)